Cyclosporin ophthalmic - Taejoon PharmAlternative Names: Cyporin N; Cyporin N Eye drop 0.05%; TJCS eye drop
Latest Information Update: 21 Sep 2016
At a glance
- Originator Taejoon Pharm
- Class Ciclosporins
- Mechanism of Action Calcineurin inhibitors; Free radical inhibitors; Immunosuppressants; Mitochondrial permeability transition pore inhibitors; P-glycoprotein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Dry eyes